Stock IdeasOct 31, 2026, 2:14 AM ETMerit Medical Systems, Inc. (MMSI) StockThe Value InvestorInvesting Group LeaderSummaryMerit Medical Systems' shares have surged ~50% in six months, driven by organic growth and a valuation re-rating to 22-23x earnings.Merit's Q3 showed 8%+ sales growth, 160bps margin expansion, and realistic EPS near $4 for FY26, with modest net debt and stable share count.Growth engines like View Point Medical and WRAPSODY have underdelivered, prompting the $45M Solo Pace acquisition to potentially add a third growth driver.With expectations now elevated and growth initiatives sputtering, I see this as a prudent moment for a more conservative stance on Merit Medical.Looking for more investing ideas like this one? Get them exclusively at Value In Corporate Events. skynesher/E+ via Getty ImagesIn May I believed that Merit Medical Systems (MMSI) was creating more growth engines, and that seems to have come through fruition with shares up some 50% over the past six months.At the time, shares tradedMore on my IG serviceIf you like to see more ideas, please subscribe to the Investing Group "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!This article was written byThe Value Investor28.25K FollowersThe Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events. As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capital allocation. Coverage includes 10 major events a month with an eye towards finding the best opportunities. Learn more.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Comments